PULMATRIX, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
PULMATRIX, INC. (PULM) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of -1.20% for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-09-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-09-17
- PULMATRIX, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2023 was 3.10%, a 24.00% increase from fiscal 2022.
- PULMATRIX, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2022 was 2.50%, a 733.33% increase from fiscal 2021.
- PULMATRIX, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2021 was 0.30%, a 86.96% decline from fiscal 2020.
- PULMATRIX, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2020 was 2.30%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -1.20% S-4/A · filed 2026-09-17 | |
| 2024-12-31 | -7.70% S-4/A · filed 2026-09-17 | 7.70% 10-K · filed 2025-03-21 |
| 2023-12-31 | 3.10% 10-K · filed 2025-03-21 | |
| 2022-12-31 | 2.50% 10-K · filed 2024-03-28 | |
| 2021-12-31 | 0.30% 10-K · filed 2023-03-30 | |
| 2020-12-31 | 2.30% 10-K · filed 2022-03-29 | -2.30% 10-K · filed 2021-03-23 |
| 2019-12-31 | -7.30% 10-K · filed 2021-03-23 | |
| 2018-12-31 | 0.00% 10-K · filed 2020-03-26 | |
| 2015-03-31 | 2.50% 10-K · filed 2015-06-10 | |
| 2014-03-31 | 0.00% 10-K · filed 2015-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |